Etiology of community-acquired pneumonia in adults: a systematic review

被引:122
作者
Shoar, Saeed [1 ]
Musher, Daniel M. [1 ,2 ]
机构
[1] Michael E DeBakey VA Med Ctr, Infect Dis Sect, Med Care Line, 2002 Holcombe Blvd,Room 4B-370, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
关键词
Community acquired pneumonia; Etiology; Pneumococcus; Antibiotic stewardship; Guidelines for management of CAP; INFECTIOUS-DISEASES-SOCIETY; SPUTUM GRAM STAIN; REQUIRING HOSPITALIZATION; PNEUMOCOCCAL PNEUMONIA; THORACIC-SOCIETY; UNITED-STATES; EPIDEMIOLOGY; DIAGNOSIS; BURDEN; STRAIN;
D O I
10.1186/s41479-020-00074-3
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background The etiology of community-acquired pneumonia (CAP) has evolved since the beginning of the antibiotic era. Recent guidelines encourage immediate empiric antibiotic treatment once a diagnosis of CAP is made. Concerns about treatment recommendations, on the one hand, and antibiotic stewardship, on the other, motivated this review of the medical literature on the etiology of CAP. Methods We conducted a systematic review of English-language literature on the etiology of CAP using methods defined by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched PubMed using a combination of the keywords 'pneumonia', 'CAP', 'etiology', 'microbiology', 'bacteriology', and 'pathogen'. We examined articles on antibiotics that were develop to treat pneumonia. We reviewed all 'related articles' as well as studies referenced by those that came up in the search. After we excluded articles that did not give sufficient microbiological data or failed to meet other predetermined criteria, 146 studies remained. Data were stratified into diagnostic categories according to the microbiologic studies that were done; results are presented as the percentage in each category of all cases in which an etiology was established. Results Streptococcus pneumoniaeremains the most common cause of CAP although declining in incidence; this decline has been greater in the US than elsewhere.Haemophilus influenzaeis the second most common cause of CAP, followed byStaphylococcus aureusand Gram negative bacilli. The incidence of all bacteria as causes of CAP has declined because, with routine use of PCR for viruses, the denominator, cases with an established etiology, has increased. Viruses were reported on average in about 10% of cases, but recent PCR-based studies identified a respiratory virus in about 30% of cases of CAP, with substantial rates of viral/bacterial coinfection. Conclusion The results of this study justify current guidelines for initial empiric treatment of CAP. With pneumococcus andHaemophiluscontinuing to predominate, efforts at antibiotic stewardship might be enhanced by greater attention to the routine use of sputum Gram stain and culture. Because viral/bacterial coinfection is relatively common, the identification of a virus by PCR does not, by itself, allow for discontinuation of the antibiotic therapy.
引用
收藏
页数:10
相关论文
共 46 条
  • [1] [Anonymous], 2018, NCHS DATA BRIEF
  • [2] Ariza-Prota MA, 2016, CASE REP PULMONOL, V2016, P5134969
  • [3] Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection
    Boulware, David R.
    Daley, Charles L.
    Merrifield, Cynthia
    Hopewell, Philip C.
    Janoff, Edward N.
    [J]. JOURNAL OF INFECTION, 2007, 55 (04) : 300 - 309
  • [4] The relative burden of community-acquired pneumonia hospitalizations in older adults: a retrospective observational study in the United States
    Brown, Joshua D.
    Harnett, James
    Chambers, Richard
    Sato, Reiko
    [J]. BMC GERIATRICS, 2018, 18
  • [5] Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia
    Carbon, C
    Moola, S
    Velancsics, I
    Leroy, B
    Rangaraju, M
    Decosta, P
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) : 691 - 703
  • [6] EFFICACY AND SAFETY OF TEMAFLOXACIN VERSUS THOSE OF AMOXICILLIN IN HOSPITALIZED ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA
    CARBON, C
    LEOPHONTE, P
    PETITPRETZ, P
    CHAUVIN, JP
    HAZEBROUCQ, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) : 833 - 839
  • [7] Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States
    Diaz, Maureen H.
    Benitez, Alvaro J.
    Cross, Kristen E.
    Hicks, Lauri A.
    Kutty, Preeta
    Bramley, Anna M.
    Chappell, James D.
    Hymas, Weston
    Patel, Anami
    Qi, Chao
    Williams, Derek J.
    Arnold, Sandra R.
    Ampofo, Krow
    Self, Wesley H.
    Grijalva, Carlos G.
    Anderson, Evan J.
    McCullers, Jonathan A.
    Pavia, Andrew T.
    Wunderink, Richard G.
    Edwards, Kathryn M.
    Jain, Seema
    Winchell, Jonas M.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2015, 2 (03):
  • [8] The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study
    Divino, Victoria
    Schranz, Jennifer
    Early, Maureen
    Shah, Hemal
    Jiang, Miao
    DeKoven, Mitch
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (01) : 151 - 160
  • [9] Pneumococcal infection in adults: burden of disease
    Drijkoningen, J. J. C.
    Rohde, G. G. U.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 45 - 51
  • [10] Bacterial Complications of Respiratory Tract Viral Illness: A Comprehensive Evaluation
    Falsey, Ann R.
    Becker, Kenneth L.
    Swinburne, Andrew J.
    Nylen, Eric S.
    Formica, Maria A.
    Hennessey, Patricia A.
    Criddle, Mary M.
    Peterson, Derick R.
    Baran, Andrea
    Walsh, Edward E.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (03) : 432 - 441